CompaniesVirion Therapeutics

Virion Therapeutics

active

Philadelphia, PA, United States

Founded 2018

About

T Cell Based Immunotherapies for Cancer

Areas of Focus

Categories

Stem Cell & Cellular TherapyNJ, NY, PA

Team (2)

Expert Leadership Built on Collaboration

Virion Therapeutics

Proven Leadership in the Biotechnology Sector

President & Chief Executive Officer

Virion Therapeutics

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

56

By Phase

PHASE1: 1

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

2027

Today

Hover over trial bars to see details

Recent Trials

NCT06070051Lead Sponsor

Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy

PHASE1Active, not recruiting

56 participants

Started: Sep 26, 2023 · Completed: Mar 31, 2026

Funding History (10)

D/A

Oct 7, 2021

D/A

Aug 25, 2021

D/A

Aug 11, 2021

D/A

Jun 8, 2021

D/A

May 13, 2021

D/A

Mar 12, 2021

D/A

Feb 24, 2021

D/A

Jan 21, 2021

D/A

Jan 4, 2021

D/A

Nov 5, 2020

Locations (1)

Headquarters

Philadelphia, PA, United States

Map

Loading map...